CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
tACS +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03994081
NCT03994081N/ACompleted
CompareCT.gov

Mechanism of Action for Transcranial Alternating Current (tACS) Stimulation for the Treatment of Major Depressive Disorder (MDD)

University of North Carolina, Chapel Hill·interventional·Posted Jun 21, 2019·Updated Sep 19, 2024

In Brief

A clinical study evaluating tACS and Sham tACS for Major Depressive Disorder and MDD. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The purpose of this research study is to use a specific type of non-invasive brain stimulation known as transcranial alternating current stimulation (tACS) to determine its effects on brain activity (measured with EEG) and mood in patients with Major Depressive Disorder (MDD).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMajor Depressive Disorder, MDD
CountriesUnited States
CollaboratorsFoundation of Hope, North Carolina

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJun 21, 2019
Enrollment StartJun 9, 2021
Primary CompletionJun 2, 2023
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 7.0 years ago

Interventions

tACSdevice

XCSITE100

Sham tACSdevice

XCSITE100